These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 27056726)
61. Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction. Li YM; Wang HB; Zheng JG; Bai XD; Zhao ZK; Li JY; Hu S World J Gastroenterol; 2015 Oct; 21(38):10853-65. PubMed ID: 26478676 [TBL] [Abstract][Full Text] [Related]
62. [Effects of short chain fatty acid on barrier disruption of human intestinal epithelial cell induced by endotoxin/lipopolysaccharide and the related mechanism]. Feng YH; Huang YL; Wang P; Wang FJ Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):214-218. PubMed ID: 29690739 [No Abstract] [Full Text] [Related]
63. Effect of heme oxygenase-1 transduced bone marrow mesenchymal stem cells on damaged intestinal epithelial cells in vitro. Cao Y; Wu BJ; Zheng WP; Yin ML; Liu T; Song HL Cell Biol Int; 2017 Jul; 41(7):726-738. PubMed ID: 28206713 [TBL] [Abstract][Full Text] [Related]
64. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB. Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864 [TBL] [Abstract][Full Text] [Related]
65. Exploring COX-2 inhibitors in tuberculosis: A whole-blood model approach for immune response and adjunt therapy evaluation. Carranza C; Sartillo-Mendoza LG; Carreto-Binaghi LE; Muñoz-Torrico M; Guzmán-Beltrán S; Torres M; Gonzalez Y; Juárez E Tuberculosis (Edinb); 2023 Dec; 143():102418. PubMed ID: 37813014 [TBL] [Abstract][Full Text] [Related]
70. The transcriptomic profile shows the protective effects of celecoxib on cirrhotic splenomegaly. Ye Y; Tang S; Tai Y; Zhao C; Tang C; Huang Z; Gao J Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):117-127. PubMed ID: 38047472 [TBL] [Abstract][Full Text] [Related]
71. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
72. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Kim WH; Matsumoto K; Bessho K; Nakamura T Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283 [TBL] [Abstract][Full Text] [Related]
73. Luo L; Zhou Z; Xue J; Wang Y; Zhang J; Cai X; Liu Y; Yang F Exp Ther Med; 2018 Sep; 16(3):1715-1722. PubMed ID: 30186392 [TBL] [Abstract][Full Text] [Related]
74. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells. Beutheu S; Ghouzali I; Galas L; Déchelotte P; Coëffier M Clin Nutr; 2013 Oct; 32(5):863-9. PubMed ID: 23428392 [TBL] [Abstract][Full Text] [Related]
75. Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment. van Dorst DCH; Mirabito Colafella KM; van Veghel R; Garrelds IM; de Vries R; Mathijssen RHJ; Danser AHJ; Versmissen J Eur J Pharmacol; 2024 Jan; 962():176199. PubMed ID: 38029870 [TBL] [Abstract][Full Text] [Related]
76. Neuroprotective effect of novel celecoxib derivatives against spinal cord injury via attenuation of COX-2, oxidative stress, apoptosisand inflammation. An Y; Li J; Liu Y; Fan M Bioorg Chem; 2020 Aug; 101():104044. PubMed ID: 32629287 [TBL] [Abstract][Full Text] [Related]
77. Effect of celecoxib in treatment of burn-induced hypermetabolism. Zhuang S; Chai J; Liu L; Yin H; Yu Y Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32285919 [TBL] [Abstract][Full Text] [Related]
78. Metabolomics analysis of gut barrier dysfunction in a trauma-hemorrhagic shock rat model. Li Z; Li J; Zhang S; Chen G; Chi S; Li X; Guo F; Zhu J; Sun B Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393232 [TBL] [Abstract][Full Text] [Related]
79. [Effects of cyclooxygenase-2 selective inhibitor celecoxib on the expression of major vault protein in rats with status epilepticus]. Song TT; Li D; Huang SP; Yang L; Wang XY; Jiang YS; Liu Y Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):440-5. PubMed ID: 27165595 [TBL] [Abstract][Full Text] [Related]
80. A Cyclooxygenase-2 Inhibitor Reduces Vascular Wall Thickness and Ameliorates Cognitive Impairment in a Cerebral Small Vessel Diseases Rat Model. Tang J; Xiao W; Li Q; Deng Q; Chu X; Chen Y; Pan D; Fu J Curr Alzheimer Res; 2015; 12(7):704-10. PubMed ID: 26159203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]